Exosomal miRNAs and breast cancer: A complex theranostics interlink with clinical significance
Biomarkers. 2023 Jun 23:1-30. doi: 10.1080/1354750X.2023.2229537. Online ahead of print.ABSTRACTBreast cancer (BC) remains the most challenging global health crisis of the current decade, impacting a large population of females annually. In the field of cancer research, the discovery of extracellular vesicles (EVs), specifically exosomes (a subpopulation of EVs), has marked a significant milestone. In general, exosomes are released from all active cells but tumor cell-derived exosomes (TDXs) have a great impact (TDXs miRNAs, proteins, lipid molecules) on cancer development and progression. TDXs regulate multiple events in ...
Source: Biomarkers - June 23, 2023 Category: Research Authors: Sayantanee Mukherjee Rajib Dhar Swathi Jonnalagadda Sukhamoy Gorai Sagnik Nag Rishav Kar Nobendu Mukerjee Dattatreya Mukherjee Rishabh Vatsa Devi Arikketh Anand Krishnan Rohit Gundamaraju Saurabh Kumar Jha Athanasios Alexiou Marios Papadakis Source Type: research
Conjunctival Microbiome Changes in Soft Contact Lens Users and Contact Lens Discomfort Patients
Conclusions: Firmicutes may serve as a potential biomarker for the CLD patients.PMID:37352111 | DOI:10.1080/1354750X.2023.2229532 (Source: Biomarkers)
Source: Biomarkers - June 23, 2023 Category: Research Authors: Kang Xiao Hang Song Zhengyu Chen Qin Long Source Type: research
Anti-Mullerian hormone and cardiometabolic status: a systematic review
CONCLUSIONS: The results of this systematic review suggest that serum AMH levels can be associated with CVD risk. This may provide new insight into the use of AMH concentrations as a predictive marker for assessing the risk of cardiovascular disease, although more well-design longitudinal studies are still necessary for this area. Future studies on this topic will hopefully provide an opportunity to run a meta-analysis; it will increase the persuasiveness of this interpretation.PMID:37309096 | DOI:10.1080/1354750X.2023.2223365 (Source: Biomarkers)
Source: Biomarkers - June 13, 2023 Category: Research Authors: Aida Fallahzadeh Fahimeh Ramezeni Tehrani Malihe Rezaee Fatemeh Mahboobifard Mina Amiri Source Type: research
Perspectives on cardiovascular biomarkers: one fits all biomarkers are out, personalization is in
Biomarkers. 2023 Jun;28(4):353. doi: 10.1080/1354750X.2023.2212913.NO ABSTRACTPMID:37183660 | DOI:10.1080/1354750X.2023.2212913 (Source: Biomarkers)
Source: Biomarkers - May 15, 2023 Category: Research Authors: Martin M öckel Source Type: research
Development and validation of a urinary microRNA biomarker panel as a tool for early detection of prostate cancer in a Chinese population
CONCLUSION: We identified a urinary miRNA biomarker panel for early detection of PCa in a Chinese population.PMID:37185057 | DOI:10.1080/1354750X.2023.2166587 (Source: Biomarkers)
Source: Biomarkers - May 15, 2023 Category: Research Authors: Nan Zhang Jianfeng Wang Shigeng Zhang Huifeng Wu Zhongyi Li Maolin Hu Source Type: research
Perspectives on cardiovascular biomarkers: one fits all biomarkers are out, personalization is in
Biomarkers. 2023 Jun;28(4):353. doi: 10.1080/1354750X.2023.2212913.NO ABSTRACTPMID:37183660 | DOI:10.1080/1354750X.2023.2212913 (Source: Biomarkers)
Source: Biomarkers - May 15, 2023 Category: Research Authors: Martin M öckel Source Type: research
Development and validation of a urinary microRNA biomarker panel as a tool for early detection of prostate cancer in a Chinese population
CONCLUSION: We identified a urinary miRNA biomarker panel for early detection of PCa in a Chinese population.PMID:37185057 | DOI:10.1080/1354750X.2023.2166587 (Source: Biomarkers)
Source: Biomarkers - May 15, 2023 Category: Research Authors: Nan Zhang Jianfeng Wang Shigeng Zhang Huifeng Wu Zhongyi Li Maolin Hu Source Type: research
